Incorporating Precision Medicine Into the Treatment of NSCLC
Dr. Kim discusses why non-small cell lung cancer should be considered the paradigm for precision medicine, and how treatment of the disease has changed over the last decade.
TAPUR Trial Leverages Genomic Testing for Precision Medicine
In this video, Dr. Edward Kim provides details on the TAPUR trial, which uses broad genomic test results to aid in precision medicine for cancer patients.
By clicking Accept, you agree to become a member of the UBM Medica Community.